Faking cancer means big bucks for young Canadian woman

This article in the Toronto edition of The Star tells it as well as coverage anywhere else: a 23 year old Canadian woman named Ashley Anne Kirilow shaved her head and her eyebrows, plucked her eyelashes, and starved herself in order to look like a cancer patient in the midst of chemotherapy.

She began a Facebook page, 'Change for a Cure', ran a phony charity, and took money from anyone who would give it to her, using a variety of lies and sob stories to recruit sympathetic volunteers to her cause. These people unwittingly hosted fundraisers for her, businesses donated products, bands played benefit concerts, and Ashley pocketed their money.

Estimates put her total take at well in excess of $20,000. If you factor in the debt she accumulated during this time, the take exceeds $50,000.

She says she did it all because her childhood sucked. Worst excuse ever.

HOW TO AVOID ASHLEYS

Below are some resources you can use to determine the legitimacy of a charity. Keep in mind that even these watchdogs don't always agree, chiefly because they tend to use different parameters. Nonetheless, here are three sources to start with:

- The Better Business Bureau's Wise Giving Alliance;
- Charity Navigator
- The American Institute of Philanthropy's CharityWatch.org

Finally, a good article from MSN Money on "How to tell good charities from bad".

A WAKE OF BITTERNESS

Ashley has surely embittered and jaded hundreds or even thousands of good-hearted people. Those people could be considered naïve or careless in not checking out her story first but they didn't do anything wrong … they just didn't do things right.

Ashley says she wants to give back the money (none of which she has). What horrible things does it say about her that she's the only one who really cares about the money.

By Ross Bonander
Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap